{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:23Z","timestamp":1791389543446,"version":"4.3.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"King Gustaf V\u2019s 80-year Foundation"},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006350","name":"Stiftelsen Clas Groschinskys Minnesfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158076","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T17:50:43Z","timestamp":1466704243000},"page":"e0158076","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antiphospholipid Antibodies in Lupus Nephritis"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":true,"given":"Ioannis","family":"Parodis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Gerhardsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Zickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sundelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Svenungsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"JS Levine","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"ref3","first-page":"67","article-title":"Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists","volume":"77","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"ref4","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"GR Hughes","year":"1986","journal-title":"J Rheumatol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2014.10.019","article-title":"Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies","volume":"14","author":"L Arnaud","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"R Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"D Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","article-title":"Antiphospholipid syndrome nephropathy in systemic lupus erythematosus","volume":"13","author":"E Daugas","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome","volume":"50","author":"MG Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13075-015-0614-5","article-title":"Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up","volume":"17","author":"J Gerhardsson","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"D Song","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2736","article-title":"Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases","volume":"11","author":"H Zheng","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","article-title":"Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis","volume":"43","author":"G Moroni","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ki.1991.155","article-title":"Significance of anti-phospholipid antibodies in patients with lupus nephritis","volume":"39","author":"G Frampton","year":"1991","journal-title":"Kidney Int"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3899\/jrheum.100650","article-title":"IgM anti-beta2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus","volume":"38","author":"T Mehrani","year":"2011","journal-title":"J Rheumatol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","article-title":"Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis","volume":"91","author":"S Bhandari","year":"1998","journal-title":"QJM"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus","volume":"72","author":"R Cervera","year":"1993","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0272-6386(12)70258-5","article-title":"Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study","volume":"20","author":"E Farrugia","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"ref19","first-page":"1684","article-title":"Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival","volume":"20","author":"PS Gulko","year":"1993","journal-title":"J Rheumatol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08860229909066969","article-title":"Catastrophic antiphospholipid syndromes in systemic lupus erythematosus","volume":"21","author":"P Stratta","year":"1999","journal-title":"Ren Fail"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"e000061","DOI":"10.1136\/lupus-2014-000061","article-title":"Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy","volume":"2","author":"I Parodis","year":"2015","journal-title":"Lupus Sci Med"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"A Zickert","year":"2014","journal-title":"Lupus Sci Med"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"EM Tan","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"M Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"JJ Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis. Contribution of renal histologic data","volume":"75","author":"III Austin HA","year":"1983","journal-title":"Am J Med"},{"issue":"2","key":"ref27","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"DD Gladman","year":"2002","journal-title":"J Rheumatol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"AS Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/art.21625","article-title":"The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials","volume":"54","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref30","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"F National Kidney","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.ajkd.2012.08.019","article-title":"A decade after the KDOQI CKD guidelines","volume":"60","author":"AS Levey","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"AS Levey","year":"2005","journal-title":"Kidney Int"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/rheumatology\/39.9.962","article-title":"Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis","volume":"39","author":"S Loizou","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"ref34","first-page":"75","article-title":"Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis","volume":"19","author":"C Fofi","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2010030274","article-title":"Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis","volume":"21","author":"AE Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10067-007-0673-3","article-title":"IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis","volume":"27","author":"C Bu","year":"2008","journal-title":"Clin Rheumatol"},{"key":"ref37","article-title":"The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort","author":"F Conti","year":"2016","journal-title":"Lupus"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"D Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1152\/physrev.00030.2001","article-title":"Annexins: from structure to function","volume":"82","author":"V Gerke","year":"2002","journal-title":"Physiol Rev"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2011-03-344671","article-title":"A novel pathway for human endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"119","author":"KL Allen","year":"2012","journal-title":"Blood"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1182\/blood-2005-07-2636","article-title":"Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome","volume":"107","author":"G Cesarman-Maus","year":"2006","journal-title":"Blood"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10875-008-9188-1","article-title":"Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome","volume":"28","author":"V Salle","year":"2008","journal-title":"J Clin Immunol"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejim.2012.04.006","article-title":"Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome","volume":"23","author":"V Salle","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2009080805","article-title":"Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis","volume":"21","author":"S Yung","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref45","article-title":"Vascular expression of annexin A2 in lupus nephritis","author":"V Salle","year":"2015","journal-title":"J Clin Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T02:59:52Z","timestamp":1656730792000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158076"}},"subtitle":[],"editor":[{"given":"Jose","family":"Crispin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158076","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]}}}